Moxifloxacin Hydrochloride and Sodium Chloride Injection is a new quinolone antibacterial drug developed by Bayer Pharmaceuticals of Germany. It was launched abroad in 1999 and is currently one of the first-choice drugs for upper respiratory tract infections. Imported injections cost about 70 yuan each. Multiply that by the number of bottles and you will know whether it is expensive. In addition, the patent for moxifloxacin hydrochloride is about to expire, and hundreds of domestic research institutions are applying for imitation. It is estimated that domestic companies will be able to imitate production in 2013 or 2014, and the price is expected to be only ten or twenty. Blocked.